Condition: Kidney Disease · Kidney Transplant · Kidney Transplant Candidates · Sponsor: Hospital Universitari Vall d'Hebron Research Institute
This is a study for hypersensitized patients who have been waiting for more than 3 years for an offer for a kidney transplant. The objective is to perform a transplant of autologous hematopoietic precursors with the aim of producing what we call an immunological reset to make the maximum number of anti-HLA antibodies disappear and thus increase the chances of the patient receiving an offer for a kidney transplant.
This description comes directly from the study's public registry record.
Oriol Bestard, MD, PhD · 932746000 · oriol.betsard@vallhebron.cat
Delphine Kervella, MD, PhD · 932746000 · delphine.kervella@vallhebron.cat
Always discuss trial participation with your own doctor first.
| Hospital Universitari Vall d'Hebron | Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06809075